BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15470656)

  • 1. Improved balance between TIMP-3 and MMP-9 after regional myocardial ischemia-reperfusion during AT1 receptor blockade.
    Sawicki G; Menon V; Jugdutt BI
    J Card Fail; 2004 Oct; 10(5):442-9. PubMed ID: 15470656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction.
    Jugdutt BI; Menon V
    J Card Fail; 2004 Feb; 10(1):74-82. PubMed ID: 14966778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
    Jugdutt BI; Menon V
    Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT1 receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: detection using proteomics.
    Jugdutt BI; Sawicki G
    Mol Cell Biochem; 2004 Aug; 263(1-2):179-88. PubMed ID: 15524179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
    Jugdutt BI; Menon V
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
    Jugdutt BI; Idikio H; Uwiera RR
    Mol Cell Biochem; 2007 Sep; 303(1-2):27-38. PubMed ID: 17426929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor blockade improves matrix metalloproteinases/tissue inhibitor of matrix metalloproteinase-1 balance and restores fibronectin expression in rat infarcted myocardium.
    Yang D; Ma S; Li D; Tang B; Yang Y
    Biochem Biophys Res Commun; 2009 Oct; 388(3):606-11. PubMed ID: 19695229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both.
    Miyazaki S; Kasai T; Miyauchi K; Miyazaki T; Akimoto Y; Takagi A; Aihara K; Kawamura M; Suwa S; Kojima S; Sumiyoshi M; Daida H
    Circ J; 2010 Jun; 74(6):1158-64. PubMed ID: 20378999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of vasopeptidase inhibitor omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction.
    Palaniyappan A; Uwiera RR; Idikio H; Jugdutt BI
    Mol Cell Biochem; 2009 Jan; 321(1-2):9-22. PubMed ID: 18777087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valsartan in the treatment of heart attack survivors.
    Jugdutt BI
    Vasc Health Risk Manag; 2006; 2(2):125-38. PubMed ID: 17319456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
    Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Esaki M; Kanamori H; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
    J Card Fail; 2007 Mar; 13(2):155-62. PubMed ID: 17395057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valsartan reverses post-translational modifications of the delta-subunit of ATP synthase during in vivo canine reperfused myocardial infarction.
    Sawicki G; Jugdutt BI
    Proteomics; 2007 Jun; 7(12):2100-10. PubMed ID: 17514685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
    Pan CH; Wen CH; Lin CS
    Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat.
    Jugdutt BI; Menon V
    Mol Cell Biochem; 2004 Jul; 262(1-2):203-14. PubMed ID: 15532725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosinopril and valsartan intervention in gene expression of Klotho, MMP-9, TIMP-1, and PAI-1 in the kidney of spontaneously hypertensive rats.
    Cheng X; Zhou Q; Lin S; Wu R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 35(10):1048-56. PubMed ID: 21051829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker.
    Jugdutt BI; Jelani A; Palaniyappan A; Idikio H; Uweira RE; Menon V; Jugdutt CE
    Circulation; 2010 Jul; 122(4):341-51. PubMed ID: 20625108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
    Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
    Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin II type 1 receptor antagonist valsartan on cardiac remodeling and left ventricular function in patients with acute ST-elevation myocardial infarction.
    Ovricenco E; Sinescu C; Dinescu S
    J Med Life; 2008; 1(3):323-33. PubMed ID: 20108509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
    Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.